Metabolic Surgery in a Pill
-
A. D. Miras; C. W. le Roux
Metabolic Surgery in a Pill Cell Metab
Publication Category: Medications
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses
- E. R. McGlone; I. Carey; V. Veličković; P. Chana; K. Mahawar; R. L. Batterham; J. Hopkins; P. Walton; R. Kinsman; J. Byrne; S. Somers; D. Kerrigan; V. Menon; C. Borg; A. Ahmed; B. Sgromo; C. Cheruvu; G. Bano; C. Leonard; H. Thom; C. W. le Roux; M. Reddy; Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses PLoS Med
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease
- W. P. Martin; Y. H. D. Chuah; M. Abdelaal; A. Pedersen; D. Malmodin; S. Abrahamsson; M. Hutter; C. Godson; E. P. Brennan; L. Fändriks; C. W. le Roux; N. G. Docherty Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease Front Endocrinol (Lausanne)
Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
-
A. Kokkinos; D. Tsilingiris; C. W. le Roux; F. Rubino; C. S. Mantzoros
Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery? Metabolism
Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study
- S. R. Kashyap; K. Kheniser; A. Aminian; P. Schauer; C. Le Roux; B. Burguera Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study Obes Sci Pract
Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity
- A. P. Goldstone; A. D. Miras; S. Scholtz; S. Jackson; K. J. Neff; L. Pénicaud; J. Geoghegan; N. Chhina; G. Durighel; J. D. Bell; S. Meillon; C. W. le Roux Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity J Clin Endocrinol Metab
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
- M. A. Glaysher; A. Mohanaruban; C. G. Prechtl; A. P. Goldstone; A. D. Miras; J. Lord; N. Chhina; E. Falaschetti; N. A. Johnson; W. Al-Najim; C. Smith; J. V. Li; M. Patel; A. R. Ahmed; M. Moore; N. Poulter; S. Bloom; A. Darzi; C. Le Roux; J. P. Byrne; J. P A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus BMJ Open
Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy
-
N. G. Docherty; C. W. Le Roux
Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy Current Opinion in Pharmacology
Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
- R. V. Cohen; T. B. Z. Petry; A. D. Miras; C. M. Aboud; B. Johnson; T. M. Dos Santos; C. W. le Roux Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial Diabetes Care